Publications
Expansion of circulating CD49b+LAG3+ type 1 regulatory T (Tr1) cells in human chronic graft-versus-host disease.
Immune responses in the immunocompromised host, J Invest Dermatol. May 16, 2020
Expansion of Circulating CD49b+LAG3+ Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host Disease
Onco-dermatology and therapies, J Invest Dermatol. May 16, 2020
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas
Onco-dermatology and therapies, Br J Dermatol. May 14, 2020
MMP2 as an independent prognostic stratifier in oral cavity cancers
Human Systems Immunology & Inflammatory Networks, Oncoimmunology May 13, 2020
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Immune responses in the immunocompromised host, N Engl J Med. May 7, 2020
Neutrophils cause a « NET » increase in skin allo- graft allogenicity
Endothelium, Inflammation & Allogenicity, Am. J. Transplant Apr 30, 2020
Immune Consequences of Endothelial Cells’ Activation and Dysfunction During Sepsis
Endothelium, Inflammation & Allogenicity, Critical Care Clinics Apr 30, 2020
FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma
Onco-dermatology and therapies, Cancers Apr 25, 2020
Identification of novel human monocyte subsets and evidence for phenotypic groups defi- ned by interindividuel variations of expression of adhesion molecules
Endothelium, Inflammation & Allogenicity, Scientific Reports Mar 10, 2020